In the intensive poultry and livestock industries, respiratory distress—ranging from localized inflammation in the bronchus or bronchi to systemic bronchitis and laryngitis—can lead to devastating economic losses. Farmers and veterinary distributors face the constant challenge of finding highly effective, stable pharmaceutical interventions that address these specific pathologies without compromising animal safety.
Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. (ZTHJ Pharma) emerges as the definitive solution for these complex needs. Established in 2008, our China/Custom bronchus or bronchi/bronchitis/laryngitis factory integrates high-tech R&D with a 21,000-square-meter state-of-the-art production facility. Having successfully passed the 2022 GMP acceptance by the Ministry of Agriculture, we provide over 100 varieties of veterinary solutions, specifically engineered to target respiratory mucosal repair and pathogen elimination.
By leveraging advanced peptide technology and specific antigens, our formulations go beyond standard treatments, offering targeted relief for inflamed airways and ensuring rapid recovery in large-scale farming operations.
Quality in veterinary respiratory medicine is defined by bioavailability and molecular stability. As a leading China/Custom bronchus or bronchi/bronchitis/laryngitis factory, ZTHJ Pharma adheres to rigorous benchmarking that exceeds standard industry expectations, ensuring that every batch of powder, premix, or oral solution maintains peak efficacy.
| Performance Metric | Industry Significance | Our Engineering Standard | Advantage |
|---|---|---|---|
| Active Ingredient Purity | Ensures effective dosage in inflamed tissues. | >99% HPLC Verified | Lower dosage requirements and reduced toxicity. |
| Particle Micronization | Critical for deep bronchus penetration in aerosol therapy. | Under 5 Microns (for powders) | Rapid absorption across the respiratory epithelium. |
| GMP Compliance | Legal and safety requirement for global trade. | 2022 New Veterinary GMP Certified | Full traceability and international export readiness. |
| Antigen Specificity | Targets the root cause of laryngitis. | R&D Integrated Peptides | Higher cure rates for viral-bacterial co-infections. |
Our facility utilizes multiple production lines to customize solutions based on the specific strain or environmental factor contributing to bronchitis in your local region, providing a truly bespoke manufacturing experience.
Strategic partnership with a China/Custom bronchus or bronchi/bronchitis/laryngitis factory like ZTHJ Pharma is not merely a procurement choice; it is a financial strategy. By reducing the Feed Conversion Ratio (FCR) through improved respiratory health, we enable our partners to achieve higher yield and lower mortality rates. Our global presence, supporting multi-language access from Russian to Arabic, ensures that our technical expertise is accessible to markets worldwide.
By integrating our Bacillus Coagulans SNZ 1969 applications and advanced pharmaceutical guides, ZTHJ Pharma provides the technical backbone for sustainable animal husbandry. Investing in our high-tech veterinary solutions ensures long-term profitability and animal welfare through superior respiratory health management.
Related products
Top Selling Products
